BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

344 related articles for article (PubMed ID: 25752402)

  • 1. Incorporating cancer stem cells in radiation therapy treatment response modeling and the implication in glioblastoma multiforme treatment resistance.
    Yu VY; Nguyen D; Pajonk F; Kupelian P; Kaprealian T; Selch M; Low DA; Sheng K
    Int J Radiat Oncol Biol Phys; 2015 Mar; 91(4):866-75. PubMed ID: 25752402
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Treating Glioblastoma Multiforme (GBM) with super hyperfractionated radiation therapy: Implication of temporal dose fractionation optimization including cancer stem cell dynamics.
    Yu VY; Nguyen D; O'Connor D; Ruan D; Kaprealian T; Chin R; Sheng K
    PLoS One; 2021; 16(2):e0245676. PubMed ID: 33524046
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Radioresistance of the breast tumor is highly correlated to its level of cancer stem cell and its clinical implication for breast irradiation.
    Qi XS; Pajonk F; McCloskey S; Low DA; Kupelian P; Steinberg M; Sheng K
    Radiother Oncol; 2017 Sep; 124(3):455-461. PubMed ID: 28923575
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Analysis of the high-dose-range radioresistance of prostate cancer cells, including cancer stem cells, based on a stochastic model.
    Saga R; Matsuya Y; Takahashi R; Hasegawa K; Date H; Hosokawa Y
    J Radiat Res; 2019 May; 60(3):298-307. PubMed ID: 31034058
    [TBL] [Abstract][Full Text] [Related]  

  • 5. MSI1 associates glioblastoma radioresistance via homologous recombination repair, tumor invasion and cancer stem-like cell properties.
    Lin JC; Tsai JT; Chao TY; Ma HI; Chien CS; Liu WH
    Radiother Oncol; 2018 Nov; 129(2):352-363. PubMed ID: 30322656
    [TBL] [Abstract][Full Text] [Related]  

  • 6. CD44-associated radioresistance of glioblastoma in irradiated brain areas with optimal tumor coverage.
    Liu WH; Lin JC; Chou YC; Li MH; Tsai JT
    Cancer Med; 2020 Jan; 9(1):350-360. PubMed ID: 31746135
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Selection of radioresistant tumor cells and presence of ALDH1 activity in vitro.
    Mihatsch J; Toulany M; Bareiss PM; Grimm S; Lengerke C; Kehlbach R; Rodemann HP
    Radiother Oncol; 2011 Jun; 99(3):300-6. PubMed ID: 21704411
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Intrinsic radiosensitivity and repair of sublethal radiation-induced damage in canine osteosarcoma cell lines.
    Fitzpatrick CL; Farese JP; Milner RJ; Salute ME; Rajon DA; Morris CG; Bova FJ; Lurie DM; Siemann DW
    Am J Vet Res; 2008 Sep; 69(9):1197-202. PubMed ID: 18764694
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Can drugs enhance hypofractionated radiotherapy? A novel method of modeling radiosensitization using in vitro data.
    Ohri N; Dicker AP; Lawrence YR
    Int J Radiat Oncol Biol Phys; 2012 May; 83(1):385-93. PubMed ID: 22265460
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Blockade of TGF-β signaling by the TGFβR-I kinase inhibitor LY2109761 enhances radiation response and prolongs survival in glioblastoma.
    Zhang M; Kleber S; Röhrich M; Timke C; Han N; Tuettenberg J; Martin-Villalba A; Debus J; Peschke P; Wirkner U; Lahn M; Huber PE
    Cancer Res; 2011 Dec; 71(23):7155-67. PubMed ID: 22006998
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cancer stem cells and radioresistance.
    Rycaj K; Tang DG
    Int J Radiat Biol; 2014 Aug; 90(8):615-21. PubMed ID: 24527669
    [TBL] [Abstract][Full Text] [Related]  

  • 12. HDAC4 and HDAC6 sustain DNA double strand break repair and stem-like phenotype by promoting radioresistance in glioblastoma cells.
    Marampon F; Megiorni F; Camero S; Crescioli C; McDowell HP; Sferra R; Vetuschi A; Pompili S; Ventura L; De Felice F; Tombolini V; Dominici C; Maggio R; Festuccia C; Gravina GL
    Cancer Lett; 2017 Jul; 397():1-11. PubMed ID: 28342984
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Estimation of the effectiveness ratio (α/β) for resistant cancer cells in U87MG human glioblastoma.
    Marmolejo-León P; Azorín-Vega EP; Jiménez-Mancilla N; Mendoza-Nava HJ; Mitsoura E; Pineda B; Torres-García E
    Appl Radiat Isot; 2018 Nov; 141():156-161. PubMed ID: 29452949
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Glioblastoma stem cells: radiobiological response to ionising radiations of different qualities.
    Pecchia I; Dini V; Ricci-Vitiani L; Biffoni M; Balduzzi M; Fratini E; Belli M; Campa A; Esposito G; Cirrone G; Romano F; Stancampiano C; Pelacchi F; Pallini R; Tabocchini MA
    Radiat Prot Dosimetry; 2015 Sep; 166(1-4):374-8. PubMed ID: 25969527
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Abrogation of radioresistance in glioblastoma stem-like cells by inhibition of ATM kinase.
    Carruthers R; Ahmed SU; Strathdee K; Gomez-Roman N; Amoah-Buahin E; Watts C; Chalmers AJ
    Mol Oncol; 2015 Jan; 9(1):192-203. PubMed ID: 25205037
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Radiosensitivity in vitro of clonogenic and non-clonogenic glioblastoma cells obtained from a human brain tumour.
    Buronfosse A; Thomas CP; Ginestet C; Doré JF
    C R Acad Sci III; 1994 Nov; 317(11):1031-41. PubMed ID: 7882140
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Evaluation of high ipsilateral subventricular zone radiation therapy dose in glioblastoma: a pooled analysis.
    Lee P; Eppinga W; Lagerwaard F; Cloughesy T; Slotman B; Nghiemphu PL; Wang PC; Kupelian P; Agazaryan N; Demarco J; Selch MT; Steinberg M; Kang JJ
    Int J Radiat Oncol Biol Phys; 2013 Jul; 86(4):609-15. PubMed ID: 23462418
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Differential radiosensitizing potential of temozolomide in MGMT promoter methylated glioblastoma multiforme cell lines.
    van Nifterik KA; van den Berg J; Stalpers LJ; Lafleur MV; Leenstra S; Slotman BJ; Hulsebos TJ; Sminia P
    Int J Radiat Oncol Biol Phys; 2007 Nov; 69(4):1246-53. PubMed ID: 17967314
    [TBL] [Abstract][Full Text] [Related]  

  • 19. HJURP knockdown disrupts clonogenic capacity and increases radiation-induced cell death of glioblastoma cells.
    Serafim RB; Cardoso C; Di Cristofaro LFM; Pienna Soares C; Araújo Silva W; Espreafico EM; Paçó-Larson ML; Price BD; Valente V
    Cancer Gene Ther; 2020 May; 27(5):319-329. PubMed ID: 31138900
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Impact of dose size in single fraction spatially fractionated (grid) radiotherapy for melanoma.
    Zhang H; Zhong H; Barth RF; Cao M; Das IJ
    Med Phys; 2014 Feb; 41(2):021727. PubMed ID: 24506618
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.